The three-judge panel of U.S. Court of Appeals for Federal Circuit negated St. Jude's pleading to rehear an appeal on the "double patenting" opinion for the 439 patent on the 11th September, 2013. Further, it removed the injunction danger that was hanging over the firm.
As 2013 drew to a close, the future looked bright for AccessClosure. The firm anticipated 2014 sales of greater than $100 million with a gross margin of greater than 70%. It was also forecasted FDA approval on a crucial product amelioration within the succeeding several months.
PUBLICATION DATE: January 21, 2014 PRODUCT #: 814074-PDF-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
H&R Sewing Machine Company
Architecture and Communication among Product Development Engineers
Bayer AG (A)
Salomon and the Treasury Securities Auction: 1992 Update
Martin Marietta: Managing Corporate Ethics (A)
Johnson & Johnson in the 1990s
Air Products and Chemicals Inc.: MIS Reorganization (A) & Project ICON (A) (Abridged)
Causes of Failure in Network Organizations
Xerox Corp.: Leadership Through Quality (B)
Investcorp and the Moneybookers Bid
